CAREER: Establishing the Efficacy of Cryomyolysis - Cryosurgery of Uterine Fibroids
职业生涯:确定冷冻肌溶解术的功效 - 子宫肌瘤冷冻手术
基本信息
- 批准号:9703326
- 负责人:
- 金额:$ 30万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Continuing Grant
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-15 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
9703326 Bischof Uterine fibroids are the most common organ disease in gynecology and the most common reason for major surgery in women. Current treatments include hysterectomy (surgical removal of the uterus), myomectomy (surgical removal of the fibroid), and most recently myolysis (destruction of the fibroid in the body). The proposed work will investigate the potential of cryosurgery of the fibroid or cryomyolysis as a conservative alternative for women who suffer from fibroids but do not wish to undergo a surgical operation to remove either the fibroid or their uterus. The hypotheses are: 1. The effectiveness of cryomyolysis is due primarily to vascular injury (damage to the vascular network nourishing the fibroid) as opposed to direct cellular injury (damage to the fibroid cells themselves), and 2. The extent of cellular destruction can be predicted based on the thermal history imposed on the tissue during cryomyolysis. By testing these hypothesis in the specific aims of the proposal, we will be able to answer the following questions: How low a temperature held for what length of time is necessary to destroy single fibroid cells and tissues? Is there a difference in the ability of cryosurgery to destroy the cells and tissues when they are in the body (in vivo) vs. when they are outside of the body (in vitro)? If a difference exists, can it be attributed to a vascular in injury mechanism inside the body (in vivo)? And finally, how does the size of the ice ball that is formed during the surgery correlate to the amount of tissue destroyed as a result of the technique? The answers to these questions are critical to a thorough understanding of the mechanism of cryosurgical destruction and, consequently, to the prudent and effective application of this surgical technique in uterine fibroids. ***
9703326 Bischof子宫肌瘤是妇科最常见的器官疾病,也是女性大手术的最常见原因。 目前的治疗方法包括子宫切除术(手术切除子宫)、子宫肌瘤切除术(手术切除子宫肌瘤)和最近的肌溶解术(破坏体内的子宫肌瘤)。 拟议的工作将调查冷冻手术的肌瘤或冷冻肌溶解术的潜力,作为一个保守的替代妇女谁患有肌瘤,但不希望接受手术切除肌瘤或子宫。 研究假设为:1.冷冻肌溶解术的有效性主要是由于血管损伤(对滋养肌瘤的血管网络的损伤),而不是直接的细胞损伤(对肌瘤细胞本身的损伤),以及2.细胞破坏的程度可以预测的基础上,在冷冻肌溶解过程中施加在组织上的热历史。 通过测试这些假设的具体目标的建议,我们将能够回答以下问题:如何保持低的温度多长时间是必要的破坏单个纤维瘤细胞和组织? 当细胞和组织在体内(体内)与体外(体外)时,冷冻手术破坏细胞和组织的能力是否有差异? 如果存在差异,是否可归因于体内(体内)血管损伤机制? 最后,在手术过程中形成的冰球的大小如何与该技术造成的组织破坏量相关联? 这些问题的答案是至关重要的冷冻手术破坏的机制的透彻理解,因此,谨慎和有效地应用这种手术技术在子宫肌瘤。 ***
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Bischof其他文献
When will nanowarmed organs crack? A preliminary 1-D model
- DOI:
10.1016/j.cryobiol.2020.10.090 - 发表时间:
2020-12-01 - 期刊:
- 影响因子:
- 作者:
Lakshya Gangwar;Joseph Kangas;Zonghu Han;Michael Etheridge;John Bischof - 通讯作者:
John Bischof
Physical limits of laser gold nanowarming
- DOI:
10.1016/j.cryobiol.2018.10.161 - 发表时间:
2018-12-01 - 期刊:
- 影响因子:
- 作者:
Kanav Khosla;Li Zhan;Aditya Bhati;Aidan Carley-Clopton;Mary Hagedorn;John Bischof - 通讯作者:
John Bischof
ATP-Bio, a new center using nanomedicine to preserve biological systems
- DOI:
10.1016/j.cryobiol.2022.11.003 - 发表时间:
2022-12-01 - 期刊:
- 影响因子:
- 作者:
John Bischof;Mehmet Toner;Allison Hubel - 通讯作者:
Allison Hubel
11. Nanowarming: A new concept in tissue and organ preservation
- DOI:
10.1016/j.cryobiol.2015.05.017 - 发表时间:
2015-08-01 - 期刊:
- 影响因子:
- 作者:
John Bischof - 通讯作者:
John Bischof
Metal foam based rewarming of vitrified systems
- DOI:
10.1016/j.cryobiol.2017.12.074 - 发表时间:
2018-04-01 - 期刊:
- 影响因子:
- 作者:
Navid Manuchehrabadi;Meng Shi;Priyatanu Roy;Jinbin Qiu;Feng Xu;Tian Jian Lu;John Bischof - 通讯作者:
John Bischof
John Bischof的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Bischof', 18)}}的其他基金
RAPID: Development of an ultrasensitive thermal contrast amplification lateral flow immunoassay for rapid, point-of-care COVID-19 diagnosis
RAPID:开发超灵敏热对比放大侧流免疫测定法,用于快速即时诊断 COVID-19
- 批准号:
2029474 - 财政年份:2020
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
NSF Engineering Research Center for Advanced Technologies for Preservation of Biological Systems (ATP-Bio)
NSF 生物系统保护先进技术工程研究中心 (ATP-Bio)
- 批准号:
1941543 - 财政年份:2020
- 资助金额:
$ 30万 - 项目类别:
Cooperative Agreement
Proposal for conference support for the ASME 2015 4th Global Congress on NanoEngineering for Medicine and Biology (Minneapolis, April 19 - 22, 2015)
ASME 2015 第四届全球医学和生物学纳米工程大会会议支持提案(明尼阿波利斯,2015 年 4 月 19 日至 22 日)
- 批准号:
1461717 - 财政年份:2015
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
ASME 2014 3rd Global Congress on Nanoengienering for Medicine and Biology, Feb 2-5, 2014 in San Francisco
ASME 2014 第三届全球医学和生物学纳米工程大会,2014 年 2 月 2-5 日在旧金山举行
- 批准号:
1361563 - 财政年份:2014
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
RF excited magnetic nanoparticles to improve thawing of vitrified biomaterials
射频激发磁性纳米粒子改善玻璃化生物材料的解冻
- 批准号:
1336659 - 财政年份:2013
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Thermal Properties in Biomaterials: The Need for Microscale Measurement in Thin Tissue Systems.
生物材料的热性能:薄组织系统中微尺度测量的需要。
- 批准号:
1236760 - 财政年份:2012
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Biotransport Symposium 2008 - Nano and multiscale frontiers in biological heat and mass transfer
2008 年生物传输研讨会 - 生物传热传质的纳米和多尺度前沿
- 批准号:
0808738 - 财政年份:2008
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Micro and Macroscale Measurement of Thermal Properties for Cryobiological Applications
低温生物学应用的微观和宏观热性能测量
- 批准号:
0313934 - 财政年份:2003
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
RESEARCH INITIATION AWARD: Quantitative Freezing of Biological Tissue
研究启动奖:生物组织的定量冷冻
- 批准号:
9410004 - 财政年份:1994
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
相似海外基金
Establishing the Therapeutic Efficacy of Alpha-1-Antitrypsin and Enoxaparin Against COVID-19
确定 Alpha-1-抗胰蛋白酶和依诺肝素针对 COVID-19 的治疗效果
- 批准号:
10588400 - 财政年份:2023
- 资助金额:
$ 30万 - 项目类别:
Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention
确定先天性心脏病体力活动生活方式干预的功效
- 批准号:
10709643 - 财政年份:2022
- 资助金额:
$ 30万 - 项目类别:
Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention
确定先天性心脏病体力活动生活方式干预的功效
- 批准号:
10586778 - 财政年份:2022
- 资助金额:
$ 30万 - 项目类别:
Establishing the Efficacy, Safety and Persistence of biopesticides based on naturally occurring beneficial bacteria
确定基于天然有益细菌的生物农药的功效、安全性和持久性
- 批准号:
BB/S007652/1 - 财政年份:2019
- 资助金额:
$ 30万 - 项目类别:
Research Grant
Establishing Quantitative Functional Metrics to Evaluate the Efficacy of Corneal Crosslinking (CXL) Therapeutic Procedures
建立定量功能指标来评估角膜交联 (CXL) 治疗程序的疗效
- 批准号:
1935817 - 财政年份:2019
- 资助金额:
$ 30万 - 项目类别:
Standard Grant
Establishing the Efficacy, Safety and Persistence of biopesticides based on naturally occurring beneficial bacteria
确定基于天然有益细菌的生物农药的功效、安全性和持久性
- 批准号:
BB/S008020/1 - 财政年份:2019
- 资助金额:
$ 30万 - 项目类别:
Research Grant
Establishing basic and clinical evidence regarding the efficacy of Lactobacillus vaginal suppositories for recurrent urinary tract infections
建立乳酸菌阴道栓剂治疗复发性尿路感染疗效的基础和临床证据
- 批准号:
17K10017 - 财政年份:2017
- 资助金额:
$ 30万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel clinical trial designs for establishing potential efficacy of complex interventions
用于确定复杂干预措施潜在功效的新颖临床试验设计
- 批准号:
MR/N015444/1 - 财政年份:2016
- 资助金额:
$ 30万 - 项目类别:
Fellowship
Establishing efficacy of a functional-restoration-based CAM pain management progr
建立基于功能恢复的 CAM 疼痛管理项目的功效
- 批准号:
8756563 - 财政年份:2014
- 资助金额:
$ 30万 - 项目类别:
Establishing efficacy of a functional-restoration-based CAM pain management progr
建立基于功能恢复的 CAM 疼痛管理项目的功效
- 批准号:
9096087 - 财政年份:2014
- 资助金额:
$ 30万 - 项目类别: